Your browser doesn't support javascript.
loading
A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda.
Musoke, Phillip; Okot, Jerom; Nanfuka, Vivien; Rwamafa, Pius; Masajjage, Joseph; Kisuule, Ivan; Nantaayi, Brandy; Ssewante, Nelson; Bongomin, Felix.
Afiliação
  • Musoke P; School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Okot J; Department of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, Gulu, Uganda.
  • Nanfuka V; Department of Internal Medicine, Kiruddu National Referral Hospital, Kampala, Uganda.
  • Rwamafa P; Department of Internal Medicine, Mulago National Referral Hospital, Kampala, Uganda.
  • Masajjage J; Department of Internal Medicine, Kiruddu National Referral Hospital, Kampala, Uganda.
  • Kisuule I; Department of Internal Medicine, Mulago National Referral Hospital, Kampala, Uganda.
  • Nantaayi B; School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Ssewante N; School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Bongomin F; School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
Risk Manag Healthc Policy ; 14: 4609-4617, 2021.
Article em En | MEDLINE | ID: mdl-34803412
ABSTRACT

INTRODUCTION:

Herbal medication use among patients with COVID-19 imposes a significant risk of drug-herbal interactions and adverse events. This study aimed to assess the prevalence and factors associated with herbal medicine use among patients hospitalized with COVID-19 attending two large COVID-19 Treatment Units (CTU) in Uganda.

METHODS:

A hospital-based descriptive cross-sectional study was conducted recruiting patients with COVID-19 hospitalized at the Mulago National Referral Hospital and Namboole Stadium CTUs. Chi-square or Fishers' exact test for categorical and Mann-Whitney U-test for numerical were used to determine the association between dependent and independent variables.

RESULTS:

The study was terminated early because of significant reduction in the number of patients hospitalized with COVID-19 and the closure of Namboole CTU. Of the anticipated 422 participants, we recruited 108 (25.6%). Of this, 58 (53.7%) were female, with a median age of 38 (range 20-75) years. Forty-nine (45.4%) had received at least one dose of the COVID-19 vaccine. Fifty-eight (57.3%) of the participants had ever used herbal medicine and the majority had used them in the past 12 months (71.9%, n = 41) either before the diagnosis of COVID-19 (85.4%, n = 35) or after (36.6%, n = 15). Being vaccinated for COVID-19 (adjusted odds ratio (aOR) 3.1, 95% confidence interval (CI) 1.4-6.8, p = 0.005) and having attained tertiary level of education (aOR 6.2, 95% CI 1.7-23.1, p = 0.006), as well as the accessibility to herbalists (aOR 31.2, 95% CI 3.7-263.2, p = 0.002) were significantly associated with herbal medication use. The majority of participants reported some improvement after using herbal medicine (80.7%, n = 46) and their doctors or nurses asked almost half of the participants about herbal medicine use (49.5%, n = 53).

CONCLUSION:

The use of herbal medicines to treat or prevent COVID-19 among hospitalized patients is a widespread practice in Uganda amidst unpublished evidence of their safety and efficacy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article